Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p186 has 73 genes in the original annotation. Currently, there are 58 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5551	PRF1	FLH2 \| HPLH2 \| P1 \| PFN1 \| PFP	perforin 1	10q22
1982	EIF4G2	AAG1 \| DAP5 \| NAT1 \| P97	eukaryotic translation initiation factor 4 gamma 2	11p15
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
6445	SGCG	35DAG \| A4 \| DAGA4 \| DMDA \| DMDA1 \| LGMD2C \| MAM \| SCARMD2 \| SCG3 \| gamma-SG	sarcoglycan gamma	13q12
4625	MYH7	CMD1S \| CMH1 \| MPD1 \| MYHCB \| SPMD \| SPMM	myosin, heavy chain 7, cardiac muscle, beta	14q12
3683	ITGAL	CD11A \| LFA-1 \| LFA1A	integrin subunit alpha L	16p11.2
4629	MYH11	AAT4 \| FAA4 \| SMHC \| SMMHC	myosin, heavy chain 11, smooth muscle	16p13.11
8735	MYH13	MyHC-IIL \| MyHC-eo	myosin, heavy chain 13, skeletal muscle	17p13
4628	MYH10	NMMHC-IIB \| NMMHCB	myosin, heavy chain 10, non-muscle	17p13
71	ACTG1	ACT \| ACTG \| BRWS2 \| DFNA20 \| DFNA26 \| HEL-176	actin gamma 1	17q25
3383	ICAM1	BB2 \| CD54 \| P3.58	intercellular adhesion molecule 1	19p13.2
79784	MYH14	DFNA4 \| DFNA4A \| FP17425 \| MHC16 \| MYH17 \| NMHC II-C \| NMHC-II-C \| PNMHH \| myosin	myosin, heavy chain 14, non-muscle	19q13.33
8672	EIF4G3	eIF-4G 3 \| eIF4G 3 \| eIF4GII	eukaryotic translation initiation factor 4 gamma 3	1p36.12
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
27	ABL2	ABLL \| ARG	ABL proto-oncogene 2, non-receptor tyrosine kinase	1q25.2
1604	CD55	CR \| CROM \| DAF \| TC	CD55 molecule (Cromer blood group)	1q32
57644	MYH7B	MHC14 \| MYH14	myosin, heavy chain 7B, cardiac muscle, beta	20q11.22
958	CD40	Bp50 \| CDW40 \| TNFRSF5 \| p50	CD40 molecule	20q12-q13.2
1525	CXADR	CAR \| CAR4/6 \| HCAR	coxsackie virus and adenovirus receptor	21q21.1
3689	ITGB2	CD18 \| LAD \| LCAMB \| LFA-1 \| MAC-1 \| MF17 \| MFI7	integrin subunit beta 2	21q22.3
637	BID	FP497	BH3 interacting domain death agonist	22q11.1
5880	RAC2	EN-7 \| Gx \| HSPC022 \| p21-Rac2	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)	22q13.1
4627	MYH9	BDPLT6 \| DFNA17 \| EPSTS \| FTNS \| MHA \| NMHC-II-A \| NMMHC-IIA \| NMMHCA	myosin, heavy chain 9, non-muscle	22q13.1
940	CD28	Tp44	CD28 molecule	2q33
841	CASP8	ALPS2B \| CAP4 \| Casp-8 \| FLICE \| MACH \| MCH5	caspase 8	2q33-q34
1605	DAG1	156DAG \| A3a \| AGRNR \| DAG \| MDDGA9 \| MDDGC7 \| MDDGC9	dystroglycan 1	3p21
22989	MYH15	-	myosin, heavy chain 15	3q13.13
941	CD80	B7 \| B7-1 \| B7.1 \| BB1 \| CD28LG \| CD28LG1 \| LAB7	CD80 molecule	3q13.3-q21
942	CD86	B7-2 \| B7.2 \| B70 \| CD28LG2 \| LAB72	CD86 molecule	3q21
836	CASP3	CPP32 \| CPP32B \| SCA-1	caspase 3	4q34
6444	SGCD	35DAG \| CMD1L \| DAGD \| SG-delta \| SGCDP \| SGD	sarcoglycan delta	5q33.3
3106	HLA-B	AS \| Bw-47 \| Bw-50 \| HLAB \| SPDA1	major histocompatibility complex, class I, B	6p21.3
3107	HLA-C	D6S204 \| HLA-JY3 \| HLAC \| HLC-C \| PSORS1	major histocompatibility complex, class I, C	6p21.3
3108	HLA-DMA	D6S222E \| DMA \| HLADM \| RING6	major histocompatibility complex, class II, DM alpha	6p21.3
3109	HLA-DMB	D6S221E \| RING7	major histocompatibility complex, class II, DM beta	6p21.3
3111	HLA-DOA	HLA-DNA \| HLA-DZA \| HLADZ	major histocompatibility complex, class II, DO alpha	6p21.3
3112	HLA-DOB	DOB	major histocompatibility complex, class II, DO beta	6p21.3
3113	HLA-DPA1	DP(W3) \| DP(W4) \| HLA-DP1A \| HLADP \| HLASB \| PLT1	major histocompatibility complex, class II, DP alpha 1	6p21.3
3115	HLA-DPB1	DPB1 \| HLA-DP \| HLA-DP1B \| HLA-DPB	major histocompatibility complex, class II, DP beta 1	6p21.3
3117	HLA-DQA1	CD \| CELIAC1 \| DQ-A1 \| GSE \| HLA-DQA	major histocompatibility complex, class II, DQ alpha 1	6p21.3
3118	HLA-DQA2	DX-ALPHA \| HLA-DXA	major histocompatibility complex, class II, DQ alpha 2	6p21.3
3119	HLA-DQB1	CELIAC1 \| HLA-DQB \| IDDM1	major histocompatibility complex, class II, DQ beta 1	6p21.3
3122	HLA-DRA	HLA-DRA1 \| MLRW	major histocompatibility complex, class II, DR alpha	6p21.3
3123	HLA-DRB1	DRB1 \| DRw10 \| HLA-DR1B \| HLA-DRB \| SS1	major histocompatibility complex, class II, DR beta 1	6p21.3
3125	HLA-DRB3	DRB1 \| DRw10 \| HLA-DR1B \| HLA-DR3B \| HLA-DRB \| SS1	major histocompatibility complex, class II, DR beta 3	6p21.3
3127	HLA-DRB5	HLA-DRB	major histocompatibility complex, class II, DR beta 5	6p21.3
3133	HLA-E	EA1.2 \| EA2.1 \| HLA-6.2 \| MHC \| QA1	major histocompatibility complex, class I, E	6p21.3
3134	HLA-F	CDA12 \| HLA-5.4 \| HLA-CDA12 \| HLAF	major histocompatibility complex, class I, F	6p21.3
3135	HLA-G	MHC-G	major histocompatibility complex, class I, G	6p21.3
3105	HLA-A	Aw-33 \| Aw-74 \| HLAA	major histocompatibility complex, class I, A	6p21.3
2534	FYN	SLK \| SYN \| p59-FYN	FYN proto-oncogene, Src family tyrosine kinase	6q21
3908	LAMA2	LAMM	laminin subunit alpha 2	6q22-q23
60	ACTB	BRWS1 \| PS1TP5BP1	actin, beta	7p22
5879	RAC1	MIG5 \| Rac-1 \| TC-25 \| p21-Rac1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)	7p22
857	CAV1	BSCL3 \| CGL3 \| LCCNS \| MSTP085 \| PPH3 \| VIP21	caveolin 1	7q31.1
25	ABL1	ABL \| JTK7 \| bcr/abl \| c-ABL \| c-ABL1 \| p150 \| v-abl	ABL proto-oncogene 1, non-receptor tyrosine kinase	9q34.1
1756	DMD	BMD \| CMD3B \| DXS142 \| DXS164 \| DXS206 \| DXS230 \| DXS239 \| DXS268 \| DXS269 \| DXS270 \| DXS272 \| MRX85	dystrophin	Xp21.2
959	CD40LG	CD154 \| CD40L \| HIGM1 \| IGM \| IMD3 \| T-BAM \| TNFSF5 \| TRAP \| gp39 \| hCD40L	CD40 ligand	Xq26